Literature DB >> 17949956

The effect of core composition in biodegradable oligomeric micelles as taxane formulations.

Myrra G Carstens1, Pascal H J L F de Jong, Cornelus F van Nostrum, Johan Kemmink, Ruud Verrijk, Leo G J de Leede, Daan J A Crommelin, Wim E Hennink.   

Abstract

Docetaxel (DCTX) and paclitaxel (PTX) are very potent anti-cancer drugs, but the currently marketed formulations, Taxotere and Taxol, respectively, are associated with vehicle-related toxicity. An attractive alternative to formulate these hydrophobic cytotoxic agents are polymeric micelles. In this study, the loading of taxanes into oligomeric micelles composed of mPEG750-b-oligo(epsilon-caprolactone)5 (mPEG750-b-OCL5) with a hydroxyl (OH), benzoyl (Bz) or naphthoyl (Np) end group was investigated. Next, the release characteristics and cytotoxicity of the loaded micelles were studied. MPEG750-b-OCL5 -OH micelles loaded with taxanes formed unstable particles with rapid leakage of the drug. In contrast, the presence of an aromatic end group (Bz or Np) resulted in the formation of small (10nm), almost monodisperse micelles with stable encapsulation of 10% (w/w) of PTX or DCTX. This was ascribed to a better compatibility between the micellar core and the drug as compared to the oligomers with the hydroxyl end group. 1H NMR studies showed that the micellar core was liquid, and that PTX was molecularly dissolved in the core. The in vitro stability was studied in PBS at 37 degrees C, which showed that leakage of PTX from 10% and 5% (w/w) loaded mPEG750-b-OCL5-Bz micelles started after 8 and 24h, respectively. The presence of albumin did not affect the stability, suggesting that the micelles are not destabilised and the drug was not extracted from the micellar core by this protein. The in vitro cytotoxic effect of the taxane-loaded micelles on C26 carcinoma cells was comparable to that of the commercial formulations, but the empty micelles were far less toxic than the Cremophor EL vehicle. The results show that mPEG-b-oligo(epsilon-caprolactone) micelles hold good promise for the formulation of taxanes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949956     DOI: 10.1016/j.ejpb.2007.08.014

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

1.  Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.

Authors:  Zhijian He; Anita Schulz; Xiaomeng Wan; Joshua Seitz; Herdis Bludau; Daria Y Alakhova; David B Darr; Charles M Perou; Rainer Jordan; Iwao Ojima; Alexander V Kabanov; Robert Luxenhofer
Journal:  J Control Release       Date:  2015-02-26       Impact factor: 9.776

Review 2.  Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.

Authors:  Chris Oerlemans; Wouter Bult; Mariska Bos; Gert Storm; J Frank W Nijsen; Wim E Hennink
Journal:  Pharm Res       Date:  2010-08-20       Impact factor: 4.200

3.  Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.

Authors:  Yifei Zhang; Yixian Huang; Wenchen Zhao; Jianqin Lu; Peng Zhang; Xiaolan Zhang; Jiang Li; Xiang Gao; Raman Venkataramanan; Song Li
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

Review 4.  Polymeric micelles: nanocarriers for cancer-targeted drug delivery.

Authors:  Yifei Zhang; Yixian Huang; Song Li
Journal:  AAPS PharmSciTech       Date:  2014-04-04       Impact factor: 3.246

5.  Improved Core Viscosity Achieved by PDLLA10kCo-Incorporation Promoted Drug Loading and Stability of mPEG2k-b-PDLLA2.4k Micelles.

Authors:  Chen Guo; Ying Zhang; Haoyang Yuan; Yu Zhang; Tian Yin; Haibing He; Jingxin Gou; Xing Tang
Journal:  Pharm Res       Date:  2022-02-03       Impact factor: 4.200

6.  Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.

Authors:  Jan-Willem Hofman; Myrra G Carstens; Femke van Zeeland; Conny Helwig; Frits M Flesch; Wim E Hennink; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2008-07-03       Impact factor: 4.580

7.  Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.

Authors:  Yong Joo Jun; Jung Hyun Park; Prakash G Avaji; Kyung Su Park; Kyung Eun Lee; Hwa Jeong Lee; Youn Soo Sohn
Journal:  Int J Nanomedicine       Date:  2017-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.